Inserm (Institut National De La Sante Et De La Recherche Medicale)
Patent owner in reexamination·1 ex parte reexams
Inserm (Institut National De La Sante Et De La Recherche Medicale)'s patents have been the subject of 1 USPTO ex parte reexamination. Its patents are most often challenged by Wellstat Ophthalmics Corporation. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top requesters
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (1)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/014,688 | Mar 3, 2021 | 10,668,129 | Synergistic Combination of Neuronal Viability Factors and Uses Thereof | Wellstat Ophthalmics Corporation | Closed |
See the full reexam picture for Inserm (Institut National De La Sante Et De La Recherche Medicale)
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.